Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 5/20 | 0.59 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.58 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.58 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.58 |
| ▸ | CALCR | P30988 | 2/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29377200 | 0.93 | NTSR1 (0.61) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29973454 | 0.92 | NMUR2 (0.57) | OPRD1OPRM1 | |
| SCHEMBL14060698 | 0.90 | NPY1R (0.55) | OPRD1NTSR1NTSR2SORT1CALCR | |
| SCHEMBL29612082 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29611528 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29611524 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29612137 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29387174 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL20707335 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 | |
| SCHEMBL29611985 | 0.90 | NPY1R (0.62) | OPRD1NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230173076-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | UNIV STRASBOURG (FR) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230173076-A1 | METABOLICALLY STABLE PEPTIDE ANALOGS | GPR119, GLP1R, GIPR | OPRD1 995/4885NTSR1 35/4885NTSR2 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.